These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 3086061)

  • 21. Intragastric pH and serum gastrin during administration of different doses of pantoprazole in healthy subjects.
    Koop H; Kuly S; Flüg M; Eissele R; Mönnikes H; Rose K; Lühmann R; Schneider A; Fischer R; Arnold R
    Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):915-8. PubMed ID: 8889461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of omeprazole induced hypergastrinaemia by SMS 201-995, a long acting somatostatin analogue in man.
    Meijer JL; Jansen JB; Crobach LF; Biemond I; Lamers CB
    Gut; 1993 Sep; 34(9):1186-90. PubMed ID: 8406151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of lansoprazole with omeprazole on 24-hour intragastric pH, acid secretion and serum gastrin in healthy volunteers.
    Bruley des Varannes S; Levy P; Lartigue S; Dellatolas F; Lemaire M; Galmiche JP
    Aliment Pharmacol Ther; 1994 Jun; 8(3):309-14. PubMed ID: 7918926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antisecretory effect and oral pharmacokinetics following low dose omeprazole in man.
    Howden CW; Forrest JA; Meredith PA; Reid JL
    Br J Clin Pharmacol; 1985 Aug; 20(2):137-9. PubMed ID: 3929808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Omeprazole in elderly duodenal ulcer patients: relationship between reduction in gastric acid secretion and fasting plasma gastrin.
    Lind T; Cederberg C; Olausson M; Olbe L
    Eur J Clin Pharmacol; 1991; 40(6):557-60. PubMed ID: 1884735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastric acid secretion and plasma gastrin during short-term treatment with omeprazole and ranitidine in duodenal ulcer patients.
    Lazzaroni M; Sangaletti O; Bianchi Porro G
    Hepatogastroenterology; 1992 Aug; 39(4):366-70. PubMed ID: 1427586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Animal pharmacodynamics of omeprazole. A survey of its pharmacological properties in vivo.
    Larsson H; Mattson H; Sundell G; Carlsson E
    Scand J Gastroenterol Suppl; 1985; 108():23-35. PubMed ID: 3858975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacology of pepsinogen secretion: influence of pentagastrin on pepsinogen secretion in man.
    Ten Kate RW; Tuynman HA; Festen HP; Pals G; Meuwissen SG
    Hepatogastroenterology; 1990 Feb; 37(1):124-7. PubMed ID: 2107135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum group I pepsinogens and gastrin in relation to gastric H+ and pepsin outputs before and after subcutaneous injection of pentagastrin.
    Waldum HL; Burhol PG; Straume BK
    Scand J Gastroenterol; 1978; 13(8):943-6. PubMed ID: 31675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of long-term treatment with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux esophagitis.
    Jansen JB; Klinkenberg-Knol EC; Meuwissen SG; De Bruijne JW; Festen HP; Snel P; Lückers AE; Biemond I; Lamers CB
    Gastroenterology; 1990 Sep; 99(3):621-8. PubMed ID: 2199288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of 'weekend therapy' with omeprazole on basal and stimulated acid secretion and fasting plasma gastrin in duodenal ulcer patients.
    Hewson EG; Yeomans ND; Angus PW; Shulkes A; Brook CW; Sewell RB; Smallwood RA
    Gut; 1988 Dec; 29(12):1715-20. PubMed ID: 3220312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-response study of omeprazole on meal-stimulated gastric acid secretion and gastrin release.
    Londong W; Londong V; Cederberg C; Steffen H
    Gastroenterology; 1983 Dec; 85(6):1373-8. PubMed ID: 6354828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of gastric acid secretion by 10 mg and 30 mg omeprazole once daily.
    Nielsen AM; Stenderup J; Wandall JH; Bonnevie O
    Scand J Gastroenterol; 1985 Dec; 20(10):1236-8. PubMed ID: 3912960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of enprostil on serum gastrin and pepsinogen A and C levels in patients on long-term treatment with omeprazole.
    Meijer JL; Jansen JB; Biemond I; Kuijpers IJ; Lamers CB
    Aliment Pharmacol Ther; 1994 Apr; 8(2):221-7. PubMed ID: 8038355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Twenty-four hour intragastric acidity during treatment with oral omeprazole.
    Pounder RE; Sharma BK; Walt RP
    Scand J Gastroenterol Suppl; 1986; 118():108-17. PubMed ID: 3460165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of trimoprostil on gastric secretion in man.
    Ishimori A; Kawamura T; Koizumi F
    Arzneimittelforschung; 1988 Jun; 38(6):833-9. PubMed ID: 3140824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Behavior of acid secretion under the long-term daily administration of omeprazol].
    Dammann HG; Müller P; Seitz HK; Simon B
    Schweiz Med Wochenschr; 1983 Jun; 113(24):895-8. PubMed ID: 6348940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Action of omeprazole (a benzimidazole derivative) on secretory responses to sham feeding and pentagastrin and upon serum gastrin and pancreatic polypeptide in duodenal ulcer patients.
    Konturek SJ; Kweicień N; Obtułowicz W; Kopp B; Oleksy J
    Gut; 1984 Jan; 25(1):14-8. PubMed ID: 6418621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity.
    Sharma BK; Walt RP; Pounder RE; Gomes MD; Wood EC; Logan LH
    Gut; 1984 Sep; 25(9):957-64. PubMed ID: 6469081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of insulin-induced hypoglycaemia on serum group I pepsinogens, serum gastrin, and plasma secretin and on gastric H+ and pepsin outputs.
    Waldum HL; Burhol PG
    Scand J Gastroenterol; 1980; 15(3):259-66. PubMed ID: 6776621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.